These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32675642)

  • 1. Community Perceptions About Use of Pre-exposure Prophylaxis Among Adolescent Girls and Young Women in Kenya.
    Escudero JN; Dettinger JC; Pintye J; Kinuthia J; Lagat H; Abuna F; Kohler P; Baeten JM; OʼMalley G; John-Stewart GC; Beima-Sofie KM
    J Assoc Nurses AIDS Care; 2020; 31(6):669-677. PubMed ID: 32675642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Awareness, Yet Low Uptake, of Pre-Exposure Prophylaxis Among Adolescent Girls and Young Women Within Family Planning Clinics in Kenya.
    Sila J; Larsen AM; Kinuthia J; Owiti G; Abuna F; Kohler PK; John-Stewart G; Pintye J
    AIDS Patient Care STDS; 2020 Aug; 34(8):336-343. PubMed ID: 32757980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High pre-exposure prophylaxis awareness and willingness to pay for pre-exposure prophylaxis among young adults in Western Kenya: results from a population-based survey.
    Begnel ER; Escudero J; Mugambi M; Mugwanya K; Kinuthia J; Beima-Sofie K; Dettinger JC; Baeten JM; John-Stewart G; Pintye J
    Int J STD AIDS; 2020 Apr; 31(5):454-459. PubMed ID: 32208816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "The Time Has Arrived": Perceptions of Behavioral Adjustments in the Context of Pre-Exposure Prophylaxis Availability Among Adolescents in South Africa.
    Giovenco D; Kuo C; Underhill K; Hoare J; Operario D
    AIDS Educ Prev; 2018 Dec; 30(6):463-473. PubMed ID: 30966763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does providing laboratory confirmed STI results impact uptake of HIV pre-exposure prophylaxis (PrEP) uptake among Kenyan adolescents girls and young women? A descriptive analysis.
    Oluoch LM; Roxby A; Mugo N; Wald A; Ngure K; Selke S; Chohan B; Kiptinness C; Tapia K; Micheni M; Maina SG; Casmir E
    Sex Transm Infect; 2021 Sep; 97(6):467-468. PubMed ID: 32917766
    [No Abstract]   [Full Text] [Related]  

  • 6. Tu'Washindi na PrEP: Working With Young Women and Service Providers to Design an Intervention for PrEP Uptake and Adherence in the Context of Gender-Based Violence.
    Hartmann M; Otticha S; Agot K; Minnis AM; Montgomery ET; Roberts ST
    AIDS Educ Prev; 2021 Apr; 33(2):103-119. PubMed ID: 33821679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitators and Barriers of Antiretroviral Therapy Initiation among HIV Discordant Couples in Kenya: Qualitative Insights from a Pre-Exposure Prophylaxis Implementation Study.
    Patel RC; Odoyo J; Anand K; Stanford-Moore G; Wakhungu I; Bukusi EA; Baeten JM; Brown JM
    PLoS One; 2016; 11(12):e0168057. PubMed ID: 27930740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Navigating Pre-exposure Prophylaxis Access: Qualitative Insights From Black Women at a Northeastern Historically Black College and University.
    Robinson M; Aidoo-Frimpong G; Nelson L; Sandoval-Rosario M; Williams B; Chandler R
    J Assoc Nurses AIDS Care; 2024 May-Jun 01; 35(3):234-244. PubMed ID: 38949902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding".
    Montgomery ET; van der Straten A; Stadler J; Hartmann M; Magazi B; Mathebula F; Laborde N; Soto-Torres L
    AIDS Behav; 2015 May; 19(5):784-93. PubMed ID: 25416076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Awareness and Willingness to use HIV Pre-exposure Prophylaxis (PrEP) Among Trans Women in China: A Community-Based Survey.
    Yan L; Yan Z; Wilson E; Arayasirikul S; Lin J; Yan H; McFarland W
    AIDS Behav; 2021 Mar; 25(3):866-874. PubMed ID: 32989576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: a qualitative study.
    Mack N; Evens EM; Tolley EE; Brelsford K; Mackenzie C; Milford C; Smit JA; Kimani J
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19157. PubMed ID: 25224616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.
    Jackson-Gibson M; Ezema AU; Orero W; Were I; Ohiomoba RO; Mbullo PO; Hirschhorn LR
    BMC Public Health; 2021 Jul; 21(1):1284. PubMed ID: 34210288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptability of pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) in Benin: a qualitative study.
    Ahouada C; Diabaté S; Gning NN; Hessou S; Batona G; Guédou FA; Béhanzin L; Zannou MD; Alary M
    AIDS Care; 2020 Feb; 32(2):242-248. PubMed ID: 31129988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Will Gay and Bisexual Men Taking Oral Pre-exposure Prophylaxis (PrEP) Switch to Long-Acting Injectable PrEP Should It Become Available?
    John SA; Whitfield THF; Rendina HJ; Parsons JT; Grov C
    AIDS Behav; 2018 Apr; 22(4):1184-1189. PubMed ID: 28913659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with knowledge of pre-exposure prophylaxis in pregnant women in Cape Town, South Africa.
    DiTullio DJ; Farley E; Gomba Y; Coates TJ; Bekker LG; Myer L; Joseph Davey DL
    Int J STD AIDS; 2019 Oct; 30(11):1063-1070. PubMed ID: 31462164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework.
    Amico KR; Wallace M; Bekker LG; Roux S; Atujuna M; Sebastian E; Dye BJ; Elharrar V; Grant RM
    AIDS Behav; 2017 May; 21(5):1361-1375. PubMed ID: 27317411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying Missed Opportunities in the Prevention of Acute HIV Infection: The Need to Provide Pre-exposure Prophylaxis Referrals to Emergency Department Patients With Increased Risk for Acquiring HIV.
    Schlenker NW; Irvin NA; Galetto GG; Dashler GM; Jones JL; Ricketts EP; Barrow GM; Saheed MO; Greenbaum AH; Rothman RE; Hsieh YH
    J Acquir Immune Defic Syndr; 2021 Nov; 88(3):e22. PubMed ID: 34321413
    [No Abstract]   [Full Text] [Related]  

  • 18. Time to Scale Up Preexposure Prophylaxis Beyond the Highest-Risk Populations? Modeling Insights From High-Risk Women in Sub-Saharan Africa.
    Grant H; Gomez GB; Kripke K; Barnabas RV; Watts C; Medley GF; Mukandavire Z
    Sex Transm Dis; 2020 Nov; 47(11):767-777. PubMed ID: 33044426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interest in HIV pre-exposure prophylaxis in men who have sex with men in West Africa (CohMSM ANRS 12324 - Expertise France).
    Coulaud PJ; Sagaon-Teyssier L; M'madi Mrenda B; Maradan G; Mora M; Bourrelly M; Dembélé Keita B; Keita AA; Anoma C; Babo Yoro SA; Dah TTE; Coulibaly C; Mensah E; Agbomadji S; Bernier A; Couderc C; Laurent C; Spire B;
    Trop Med Int Health; 2018 Oct; 23(10):1084-1091. PubMed ID: 30055043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge and Acceptability of HIV pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) in Ghana.
    Ogunbajo A; Leblanc NM; Kushwaha S; Boakye F; Hanson S; Smith MDR; Nelson LE
    AIDS Care; 2020 Mar; 32(3):330-336. PubMed ID: 31597455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.